Morphiex is a biotech firm that specializes in utilizing the immune system to combat cancer. They have developed a unique CD47 immune checkpoint inhibitor that functions in two ways.
Related
100 Clinical Results associated with Morphiex Biotherapeutics, Inc.
Login to view more data
0 Patents (Medical) associated with Morphiex Biotherapeutics, Inc.
Login to view more data
100 Deals associated with Morphiex Biotherapeutics, Inc.
Login to view more data
100 Translational Medicine associated with Morphiex Biotherapeutics, Inc.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.